Therapeutic Peptides_Synbio Technologies

Home > Peptide Services > Therapeutic Peptides

General Introduction of Therapeutic Peptides

Therapeutic peptides are a class of bioactive molecules formed by amino acids linked through peptide bonds, representing an important branch of the biopharmaceutical field. Their core advantages include precise structure, strong targeting capability, and low side effects, making them widely applicable in areas such as oncology, metabolic diseases, and immunomodulation.

Synbio Technologies provides an extensive portfolio of ready-to-ship therapeutic peptide products, all backed by accurate and timely delivery.

Highlights

Extensive Peptide Diversity
Purity Level ≥98.0%
Multiple Quality Controls
Fast Turnaround

Service Details

Peptide	Cas No	Molecular Formula	Molecular Weight	Sequence	Purity	COA
BPC-157	137525-51-0	C62H98N16O22	1419.54	H-Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val-OH	≥ 98.0%	BPC-157 COA
CJC-1295	863288-34-0	C152H252N44O42	3367.90	H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2	≥ 98.0%	CJC-1295 COA
DSIP	62568-57-4	C35H48N10O15	848.81	H-Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu-OH	≥ 98.0%	DSIP COA
Epitalon (AEDG)	307297-39-8	C14H22N4O9	390.34	H-Ala-Glu-Asp-Gly-OH	≥ 98.0%	Epitalon (AEDG) COA
GHK-Cu	89030-95-5	C14H22N6O4Cu	401.91	H-Gly-His-Lys-OH · Cu	≥ 98.0%	GHK-Cu COA
Ipamorelin	170851-70-4	C38H49N9O5	711.85	Aib-His-D-2-Nal-D-Phe-Lys-NH2	≥ 98.0%	Ipamorelin COA
MOTS-C	1627580-64-6	C101H152N28O22S2	2174.59	H-Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg-OH	≥ 98.0%	MOTS-C COA
Selank	129954-34-3	C33H57N11O9	751.87	H-Thr-Lys-Pro-Arg-Pro-Gly-Pro-OH	≥ 98.0%	Selank COA
Semax	80714-61-0	C37H51N9O10S	813.92	H-Met-Glu-His-Phe-Pro-Gly-Pro-OH	≥ 98.0%	Senmax COA
SS-31	736992-21-5	C32H49N9O	639.79	D-Arg-Dmt-Lys-Phe-NH2	≥ 98.0%	SS-31 COA
TB-500	77591-33-4	C212H350N56O78S	4963.44	Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser-OH	≥ 98.0%	TB-500 COA
Tesamorelin	218949-48-5	C221H366N72O67S	5135.86	trans-3-Hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gl n-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2	≥ 98.0%	Tesamorelin COA
Thymosin Alpha-1	62304-98-7	C129H215N33O55	3108.28	Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH	≥ 98.0%	Thymosin Alpha-1 COA

* For ≤ 100g in stock, for >100g Quote

* Keep in dark and cool dry place.

Order Now Quote

Deliverables

Peptide Products

HPLC Reports

MS Reports

Certificate of Analysis

FAQs

What is the difference between drug peptides and ordinary research peptides?

Therapeutic peptides are produced under drug development requirements and are intended for clinical use. Compared to standard research peptides, they have stricter quality control, process stability, and regulatory compliance. Therapeutic peptides must be manufactured under GMP conditions and meet all quality and safety standards required by regulatory agencies.

How do you ensure peptide quality?

We have a robust quality control system with advanced instruments (HPLC, LC-MS, MS/MS). All starting materials, intermediates, and final products undergo thorough testing. Each product is accompanied by a detailed COA including HPLC purity and mass spectrometry data.

More FAQs>>

Get in Touch with Us